Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Winning Strategies and Solutions in Pain Management and Sports Medicine

When Bills safety Damar Hamlin got injured during a game against the Cincinnati Bengals in January, the world of sports held its breath. Thankfully, Hamlin is on the road to recovery, but his injury served as a reminder of the importance of sports medicine and interventional pain management. One of the most Internationally recognized…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

 
When Bills safety Damar Hamlin got injured during a game against the Cincinnati Bengals in January, the world of sports held its breath. Thankfully, Hamlin is on the road to recovery, but his injury served as a reminder of the importance of sports medicine and interventional pain management.

One of the most Internationally recognized and respected names in sports and pain management is Dr. Chad Stephens, President and Managing Partner/Physician at Noble Pain Management & Sports Medicine. Stephens noted the rare instance of this type of injury in football.

Still, anyone involved in sports from school to the professional level knows, pain is part of the game. And in America, sports or no sports, an estimated 100 million people suffer from chronic pain.

Dr. Stephens firmly believes in educating patients, sports, and healthcare communities on effective pain management strategies and treatments. He sat down with #WinTheDay host, Chase Wasson, to talk about his career and his approach to pain management and sports medicine.

“The reason I enjoy the field I’m in is because I see people on a continual basis, and I get to watch the progress of their life,” Stephens said. “What I mean by that is functional improvement through injury, or chronic pain conditions, and getting them back to doing things they enjoy at a higher level than being hampered by whatever is in their way.”

Wasson and Stephens discuss…

● The learnings and experiences that impacted how Dr. Stephens treats patients today

● How patient needs guide the treatment plan journey

● Using interpersonal skills to build trust and rapport with patients and colleagues

“When I teach a course on the weekend, a lot of times I will ask the radiology techs, and I’ll say when was the last time a doctor called you by your name,” Stephens said. “And some of them never had a doctor call them by their name, and I look at all the people in the course and say, the first thing you need to understand when you walk into the room is you’re not the most important person.”

About Dr. Chad Stephens

Dr. Chad Stephens believes the right representation can be the difference between success and failure. Stephens is a decades-long educator of sports and pain medicine innovation. He’s an engaged educator and speaker who has been seen and heard on numerous radio and TV stations throughout the country, including regular contributions on Fox News. His mission is to help patients determine the true source of their pain and create customized plans designed to return patients to their everyday, active lives.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512